{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:17:49Z","timestamp":1788247069255,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"DOI":"10.1038\/s41417-026-01052-5","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:09:20Z","timestamp":1788203360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hsa_circ_0136682 driving malignancy in breast cancer through the NCL\/c-Myc axis"],"prefix":"10.1038","author":[{"given":"Xinyue","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhe","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-3096","authenticated-orcid":false,"given":"Yingying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1052_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2021.11.007","volume":"83","author":"WT Rahman","year":"2022","unstructured":"Rahman WT, Helvie MA. Breast cancer screening in average and high-risk women. Best Pract Res Clin Obstet Gynaecol. 2022;83:3\u201314.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1052_CR2","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","volume":"365","author":"U Veronesi","year":"2005","unstructured":"Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005;365:1727\u201341.","journal-title":"Lancet"},{"key":"1052_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"key":"1052_CR4","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radio. 2022;95:20211033.","journal-title":"Br J Radio"},{"key":"1052_CR5","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.ctrv.2022.102339","volume":"104","author":"D Trapani","year":"2022","unstructured":"Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, et al. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022;104:102339.","journal-title":"Cancer Treat Rev"},{"key":"1052_CR6","first-page":"1566","volume":"7","author":"H-F Liang","year":"2017","unstructured":"Liang H-F, Zhang X-Z, Liu B-G, Jia G-T, Li W-L. Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271. Am J Cancer Res. 2017;7:1566\u201376.","journal-title":"Am J Cancer Res"},{"key":"1052_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1287-1","volume":"10","author":"Z Liu","year":"2019","unstructured":"Liu Z, Zhou Y, Liang G, Ling Y, Tan W, Tan L, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10:55.","journal-title":"Cell Death Dis"},{"key":"1052_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/0008-5472.CAN-22-1923","volume":"83","author":"Y Shen","year":"2023","unstructured":"Shen Y, Zhang N, Chai J, Wang T, Ma C, Han L, et al. CircPDIA4 induces gastric cancer progression by promoting ERK1\/2 activation and enhancing biogenesis of oncogenic circRNAs. Cancer Res. 2023;83:538\u201352.","journal-title":"Cancer Res"},{"key":"1052_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11010-021-04286-z","volume":"477","author":"J Ju","year":"2022","unstructured":"Ju J, Song Y, Chen X, Wang T, Liu C, Wang K. circRNA is a potential target for cardiovascular diseases treatment. Mol Cell Biochem. 2022;477:417\u201330.","journal-title":"Mol Cell Biochem"},{"key":"1052_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.941123","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Y, Yu F, Li X, Gao H, Li P. The circRNA-miRNA\/RBP regulatory network in myocardial infarction. Front Pharm. 2022;13:941123.","journal-title":"Front Pharm"},{"key":"1052_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jnr.24356","volume":"98","author":"J Zang","year":"2020","unstructured":"Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J Neurosci Res. 2020;98:87\u201397.","journal-title":"J Neurosci Res"},{"key":"1052_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1763","volume":"14","author":"M Zhuang","year":"2024","unstructured":"Zhuang M, Zhang X, Ji J, Zhang H, Shen L, Zhu Y, et al. Exosomal circ-0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7\/NRF2 axis. Clin Transl Med. 2024;14:e1763.","journal-title":"Clin Transl Med"},{"key":"1052_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.omtn.2021.07.003","volume":"26","author":"X Wang","year":"2021","unstructured":"Wang X, Chen M, Fang L. hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3. Mol Ther Nucleic Acids. 2021;26:122\u201334.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1052_CR14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.csbj.2021.01.018","volume":"19","author":"X Tang","year":"2021","unstructured":"Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J. 2021;19:910\u201328.","journal-title":"Comput Struct Biotechnol J"},{"key":"1052_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3892\/ijmm.2023.5284","volume":"52","author":"S Thongchot","year":"2023","unstructured":"Thongchot S, Aksonnam K, Thuwajit P, Yenchitsomanus P-T, Thuwajit C. Nucleolin-based targeting strategies in cancer treatment: focus on cancer immunotherapy (Review). Int J Mol Med. 2023;52:81.","journal-title":"Int J Mol Med"},{"key":"1052_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03095-4","volume":"11","author":"R Wu","year":"2020","unstructured":"Wu R, Li L, Bai Y, Yu B, Xie C, Wu H, et al. The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression. Cell Death Dis. 2020;11:908.","journal-title":"Cell Death Dis"},{"key":"1052_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tcb.2022.03.003","volume":"32","author":"T Santos","year":"2022","unstructured":"Santos T, Salgado GF, Cabrita EJ, Cruz C. Nucleolin: a binding partner of G-quadruplex structures. Trends Cell Biol. 2022;32:561\u20134.","journal-title":"Trends Cell Biol"},{"key":"1052_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104841","volume":"158","author":"X Wu","year":"2020","unstructured":"Wu X, Xiao Y, Ma J, Wang A. Circular RNA: A novel potential biomarker for skin diseases. Pharmacol Res. 2020;158:104841.","journal-title":"Pharmacol Res"},{"key":"1052_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omtn.2021.05.022","volume":"25","author":"AR Sharma","year":"2021","unstructured":"Sharma AR, Bhattacharya M, Bhakta S, Saha A, Lee S-S, Chakraborty C. Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential. Mol Ther Nucleic Acids. 2021;25:355\u201371.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1052_CR20","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s12094-023-03173-x","volume":"25","author":"R Guo","year":"2023","unstructured":"Guo R, Zhang R. Dual effects of circRNA in thyroid and breast cancer. Clin Transl Oncol. 2023;25:3321\u201331.","journal-title":"Clin Transl Oncol"},{"key":"1052_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pbiomolbio.2019.03.007","volume":"147","author":"Q Wu","year":"2019","unstructured":"Wu Q, Liang S, Ochi T, Chirgadze DY, Huiskonen JT, Blundell TL. Understanding the structure and role of DNA-PK in NHEJ: How X-ray diffraction and cryo-EM contribute in complementary ways. Prog Biophys Mol Biol. 2019;147:26\u201332.","journal-title":"Prog Biophys Mol Biol"},{"key":"1052_CR22","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.3892\/or.2017.5634","volume":"37","author":"G Sun","year":"2017","unstructured":"Sun G, Yang L, Dong C, Ma B, Shan M, Ma B. PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients. Oncol Rep. 2017;37:3536\u201342.","journal-title":"Oncol Rep"},{"key":"1052_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10549-013-2785-6","volume":"143","author":"WM Ciszewski","year":"2014","unstructured":"Ciszewski WM, Tavecchio M, Dastych J, Curtin NJ. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Breast Cancer Res Treat. 2014;143:47\u201355.","journal-title":"Breast Cancer Res Treat"},{"key":"1052_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1139\/bcb-2020-0219","volume":"99","author":"X Leng","year":"2021","unstructured":"Leng X, Huang G, Ding J, Ma F. Circ_0000043 promotes the proliferation, migration, invasiveness, and epithelial\u2013mesenchymal transition in breast cancer cells via the miR-136\u2013Smad3 axis. Biochem Cell Biol. 2021;99:277\u201385.","journal-title":"Biochem Cell Biol"},{"key":"1052_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107204","volume":"204","author":"J Zhou","year":"2024","unstructured":"Zhou J, Xu H, Li X, Liu H, Sun Z, Li J, et al. Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells. Pharmacol Res. 2024;204:107204.","journal-title":"Pharmacol Res"},{"key":"1052_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fgene.2020.00485","volume":"11","author":"M Liu","year":"2020","unstructured":"Liu M, Luo C, Dong J, Guo J, Luo Q, Ye C, et al. CircRNA_103809 Suppresses the Proliferation and Metastasis of Breast Cancer Cells by Sponging MicroRNA-532-3p (miR-532-3p). Front Genet. 2020;11:485.","journal-title":"Front Genet"},{"key":"1052_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01321-x","volume":"20","author":"Y Fan","year":"2021","unstructured":"Fan Y, Wang J, Jin W, Sun Y, Xu Y, Wang Y, et al. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer. Mol Cancer. 2021;20:25.","journal-title":"Mol Cancer"},{"key":"1052_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canlet.2018.03.035","volume":"425","author":"R Zhou","year":"2018","unstructured":"Zhou R, Wu Y, Wang W, Su W, Liu Y, Wang Y, et al. Circular RNAs (circRNAs) in cancer. Cancer Lett. 2018;425:134\u201342.","journal-title":"Cancer Lett"},{"key":"1052_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0014-4827(81)90041-0","volume":"136","author":"MA Lischwe","year":"1981","unstructured":"Lischwe MA, Richards RL, Busch RK, Busch H. Localization of phosphoprotein C23 to nucleolar structures and to the nucleolus organizer regions. Experimental Cell Res. 1981;136:101\u2013109.","journal-title":"Experimental Cell Res"},{"key":"1052_CR30","doi-asserted-by":"publisher","first-page":"19025","DOI":"10.1074\/jbc.273.30.19025","volume":"273","author":"P Bouvet","year":"1998","unstructured":"Bouvet P, Diaz J-J, Kindbeiter K, Madjar J-J, Amalric F. Nucleolin interacts with several ribosomal proteins through its RGG domain. J Biol Chem. 1998;273:19025\u20139.","journal-title":"J Biol Chem"},{"key":"1052_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2017.07.025","volume":"186","author":"W Jia","year":"2017","unstructured":"Jia W, Yao Z, Zhao J, Guan Q, Gao L. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci. 2017;186:1\u201310.","journal-title":"Life Sci"},{"key":"1052_CR32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s13277-015-3889-x","volume":"37","author":"J Yan","year":"2015","unstructured":"Yan J, Zhang Y, Ren C, Shi W, Chen L. Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer. Tumor Biol. 2015;37:905\u201310.","journal-title":"Tumor Biol"},{"key":"1052_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0547-5","volume":"32","author":"Y Yang","year":"2015","unstructured":"Yang Y, Yang C, Zhang J. C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1\/2 and Akt in gastric cancer. Med Oncol. 2015;32:76.","journal-title":"Med Oncol"},{"key":"1052_CR34","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-07-5723","volume":"68","author":"S Soundararajan","year":"2008","unstructured":"Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 2008;68:2358\u201365.","journal-title":"Cancer Res"},{"key":"1052_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0860-7","volume":"17","author":"X Wang","year":"2018","unstructured":"Wang X, Yu H, Sun W, Kong J, Zhang L, Tang J, et al. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Mol Cancer. 2018;17:110.","journal-title":"Mol Cancer"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01052-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:03:51Z","timestamp":1788246231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01052-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":35,"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01052-5","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal work was performed in compliance with relevant guidelines by the Ethical Committee of China Pharmaceutical University (Ethical number. 2024-09-120).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}